Department of Health and Human Services· Notice
Outsourcing Facility Fee Rates for Fiscal Year 2026
effective in 63d
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the fiscal year (FY) 2026 rates for the establishment and reinspection fees related to entities that compound human drugs and elect to register as outsourcing facilities under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FD&C Act…
Owner check — Effective-date item: save the source and decide whether counsel, bookkeeping, or operations should review.